1. Scrip
  3. >>South Korea

What's Keeping Korea From Adopting Decentralized Clinical Trials?

Digital, Medical Literacy, Hybrid Approaches Highlighted

 
• By Jung Won Shin

The current status of decentralized clinical trials in Korea and the country’s efforts to boost activity in this area were discussed at the recent Bio Korea meeting, with cultural and medical practices, along with technological and medical literacy, among the areas seen as affecting broader adoption of the various elements of the approach.

Jaeseong Oh, Professor, Seoul National University Hospital
Korean Patients Prefer Hospital Visits, Face-To-Face Treatment • Source: Jung Won Shin

Decentralized clinical trials (DCTs) have been rapidly transforming the global clinical research environment by enabling faster recruitment through expansion of patient pools and the reduction of burdens for patient participation.

The various advantages of the approach were particularly highlighted during the COVID-19 pandemic, when it became difficult to enrol patients through standard means

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Focus On Asia